Company / Cash per Share
Cyclerion Therapeutics, Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.27
FY2025
5-year range
$0.31 / $3.48
FY2021-FY2025
Trend
-58.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.48 to $1.27 over the past 2 years.
Based on SEC 10-K filings.
1.27 in FY2025 with a 5-year CAGR of -8.4%.
Declined from $3.48 to $1.27 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +60.4%
- 5-Year CAGR
- -8.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 58.4% year-over-year.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.27 | -58.4% |
| FY2024 | $3.06 | -12.1% |
| FY2023 | $3.48 | +1028.7% |
| FY2022 | $0.31 | -82.6% |
| FY2021 | $1.77 | -9.9% |
| FY2020 | $1.97 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026